Clinical Trial Update: E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study evaluating lenvatinib in combination with dacarbazine versus dacarbazine alone as first-line t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Stage IV Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-10